Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects
NCT00166322
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
PROCEDURE:
IBZM-SPECT (bolus and constant infusion paradigm)
Sponsor
Ludwig-Maximilians - University of Munich